This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

(Circulation Research. 2004;94:e14.)
© 2004 American Heart Association, Inc.

Retraction

An extract of the first 100% of the full text is provided, because this article has no abstract.

After a finding by the Office of Research Integrity (ORI) that Dr Craig H. Gelband falsified data in the reporting of research and misrepresented current/voltage data to be results from different experimental models or preparations, Dr Gelband has requested retraction of Figure 5A from the following article previously published in Circulation Research:

Reaves PY, Gelband CH, Wang H, Yang H, Lu D, Berecek KH, Katovich, MJ, Raizada MK. Permanent cardiovascular protection from hypertension by the AT₁ receptor antisense gene therapy in hypertensive rat offspring. Circ Res. 1999;85:e44–e50.

Based on the ORI findings, all coauthors involved in this study, other than Dr Gelband, had no knowledge of any scientific impropriety related to the collection, analysis, or presentation of data in this manuscript. Notice of the ORI findings of scientific misconduct against Dr Gelband can be found in the Federal Register (Volume 68, Number 217, pages 63797–63799).